| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_555896a2f43ea629dbc0f99b94cfd297 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-68 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2006-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0949243faa81d001c2e10f5d418447d8 |
| publicationDate |
2006-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006286571-A1 |
| titleOfInvention |
Methods of predicting methotrexate efficacy and toxicity |
| abstract |
The present invention provides methods for analyzing genetic and/or metabolite biomarkers to individualize methotrexate (MTX) therapy. For example, the assay methods of the present invention are useful for predicting whether a patient will respond to MTX and/or has a risk of developing toxicity to MTX based upon the genotype of one or more folate pathway genes. The assay methods of the present invention are also useful for optimizing the dose of MTX in a patient already receiving the drug to achieve therapeutic efficacy and/or reduce toxic side-effects based upon the genotype of one or more folate pathway genes. In addition, the assay methods of the present invention are useful for predicting or optimizing the therapeutic response to MTX in a patient based upon the methotrexate polyglutamate and/or folate polyglutamate levels in a sample from the patient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012231463-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010239646-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010077722-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012132797-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8541243-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010203507-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010203508-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015130852-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11468355-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011207164-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11216742-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102272326-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015018244-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010006070-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102272326-B |
| priorityDate |
2005-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |